Monitoring the Bone Marrow and Blood Counts

Managing SRP54 deficiency involves closely monitoring your child’s “blood-making factory”—the bone marrow. Because the SRP54 mutation disrupts how white blood cells develop, your child’s medical team will use specific laboratory tests and procedures to track their health and watch for potential complications over time ^[1][2].

Tracking the Absolute Neutrophil Count (ANC)

The most important laboratory value for your child is the Absolute Neutrophil Count (ANC). This number is calculated from a standard Complete Blood Count (CBC) and tells you exactly how many “first-responder” white blood cells are available to fight infections ^[2][3].

• Defining Severity: In many cases of SRP54 deficiency, the ANC is persistently below 500 cells per microliter, which is classified as severe congenital neutropenia (SCN) ^[2][1].
• Monitoring Patterns: While most children with this condition have a steady, low ANC, some variants (such as the p.T117del mutation) may cause cyclic neutropenia, where the counts rise and fall in a predictable pattern ^[4][5]. Regular blood tests help your doctor determine your child’s specific pattern.

The Bone Marrow Evaluation

To understand why the white blood cells are not entering the bloodstream, doctors perform a bone marrow aspiration and biopsy. This procedure involves taking a small sample of the liquid marrow and a tiny piece of the bone tissue, usually from the hip ^[6].

• The Pathology Report: A common finding in SRP54 deficiency is maturation arrest at the promyelocyte stage ^[1][4]. This means the cells start developing normally but “get stuck” at an early stage called a promyelocyte and never become mature, infection-fighting neutrophils ^[5][1]. Doctors may also see cells that look slightly abnormal under a microscope.

Monitoring for Acquired Marrow Changes

Because SRP54 deficiency is a bone marrow failure syndrome, there is a risk that the bone marrow could change over time. This process is called clonal evolution, where cells develop new, acquired mutations that could potentially lead to Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) ^[7][8].

• Understanding the Risk: The exact risk frequency in SRP54 deficiency is still unknown. In one group of 23 patients followed for 15 years, no one developed a malignancy ^[8]. However, at least one case of AML has been reported in a patient with a specific SRP54 mutation, highlighting the need for surveillance ^[8].
• Surveillance Strategy: Based on general guidelines for Severe Congenital Neutropenia, specialists often recommend periodic marrow examinations (sometimes yearly, though this should be individualized) ^[7]. During this exam, doctors look for:
  • Cytogenetic Abnormalities: Changes in the number or shape of chromosomes (like monosomy 7) ^[7].
  • Somatic Mutations: Acquired mutations in genes such as CSF3R or RUNX1. It is important to know that finding an acquired mutation like CSF3R does not automatically mean leukemia is present. It must be interpreted by an experienced marrow-failure team ^[8][9].

Identifying these changes early allows the care team to track risks and discuss treatment options, such as a stem cell transplant, if they become necessary ^[10][8]. Regular monitoring is a crucial tool for ensuring your child’s bone marrow remains as healthy as possible.